Varex Imaging (NASDAQ:VREX – Free Report) had its price objective decreased by Oppenheimer from $30.00 to $23.00 in a report published on Friday morning,Benzinga reports. Oppenheimer currently has an outperform rating on the stock.
A number of other brokerages have also recently weighed in on VREX. StockNews.com cut shares of Varex Imaging from a “buy” rating to a “hold” rating in a research report on Thursday, January 30th. B. Riley reiterated a “buy” rating and issued a $22.00 target price (up previously from $21.00) on shares of Varex Imaging in a report on Friday.
Check Out Our Latest Stock Analysis on Varex Imaging
Varex Imaging Price Performance
Varex Imaging (NASDAQ:VREX – Get Free Report) last announced its quarterly earnings results on Thursday, February 6th. The company reported $0.07 EPS for the quarter, beating the consensus estimate of $0.04 by $0.03. Varex Imaging had a positive return on equity of 3.96% and a negative net margin of 5.79%. As a group, sell-side analysts forecast that Varex Imaging will post 0.63 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Varex Imaging
A number of hedge funds and other institutional investors have recently bought and sold shares of VREX. FMR LLC increased its stake in Varex Imaging by 4,739.2% during the third quarter. FMR LLC now owns 200,341 shares of the company’s stock worth $2,388,000 after purchasing an additional 196,201 shares during the period. Barclays PLC grew its holdings in shares of Varex Imaging by 15.3% in the third quarter. Barclays PLC now owns 97,883 shares of the company’s stock valued at $1,166,000 after purchasing an additional 12,966 shares in the last quarter. Assenagon Asset Management S.A. increased its stake in Varex Imaging by 37.3% during the 3rd quarter. Assenagon Asset Management S.A. now owns 185,506 shares of the company’s stock worth $2,211,000 after buying an additional 50,382 shares during the period. Point72 Asset Management L.P. acquired a new stake in Varex Imaging during the 3rd quarter worth approximately $415,000. Finally, BNP Paribas Financial Markets boosted its position in Varex Imaging by 1,359.9% in the 3rd quarter. BNP Paribas Financial Markets now owns 52,295 shares of the company’s stock valued at $623,000 after buying an additional 48,713 shares during the period.
Varex Imaging Company Profile
Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.
Recommended Stories
- Five stocks we like better than Varex Imaging
- What Are Trending Stocks? Trending Stocks Explained
- MarketBeat Week in Review – 02/03 – 02/07
- How to Calculate Inflation Rate
- Meta Platforms Continues to Prove Why It’s a Premier Play on AI
- Energy and Oil Stocks Explained
- IBM’s AI Bet Pays Off—What’s Next for Investors?
Receive News & Ratings for Varex Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varex Imaging and related companies with MarketBeat.com's FREE daily email newsletter.